Approvals/TGA/SANDOSTATIN LAR octreotide (as acetate) 10 mg modified release injection vial plus diluent prefilled syringe composite pack

Approved

STANDARD

SANDOSTATIN LAR octreotide (as acetate) 10 mg modified release injection vial plus diluent prefilled syringe composite pack

Approval Id: 3ab0c16e8ef94b39
Product Name: SANDOSTATIN LAR octreotide (as acetate) 10 mg modified release injection vial plus diluent prefilled syringe composite pack
Artg Id: 227962
Artg Name: SANDOSTATIN LAR octreotide (as acetate) 10 mg modified release injection vial plus diluent prefilled syringe composite pack
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2015-03-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/015e5a25df85af4ddb78e35674619d8d.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/a558a04ebcb5ed07822ab38a9f5948ce.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

3ab0c16e8ef94b39

Type

Standard